The next driving force in the market could come from these historical outperformers.
Investors are underappreciating a large segment of the market. These ETFs can help you invest in it.
Thinking small could potentially make investors big money.
You might be a lot closer to $1 million than you think.
Despite large-cap dominance, signs suggest a shift to small-cap leadership. Valuations, positive Q3 results, and historical patterns point to potential gains.
This class of stocks has been largely left behind, and you can buy them all with a simple index fund.
Solar-tracker maker Array is up 30.96% in the past three months. Wall Street has a "moderate-buy" rating on the stock and a target of $22.38, a 39.64% upside.
Small-cap chemical and plastic maker Trinseo, tracked by the S&P 600 index, rose Thursday despite Morgan Stanley lowering the stock's price target.
Small-cap biotech Catalyst Pharmaceuticals has been outperforming the broader market amid earnings and revenue acceleration. It joined the S&P 600 last month.
Small-cap staffing specialist Cross Country Healthcare gained 4% Wednesday, extending its streak for the third day. The firm topped EPS views since July 2019.